Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus enalapril long-term extension study in pediatric hypertension
2009-017029-20Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Aliskiren with Enalapril (2 arms). Primary endpoints: Safety and Tolerability. Started May 2010; status: completed.
02
Drugs
aliskirenenalapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2009-017029-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017029-20.